首页> 美国卫生研究院文献>Interventional Cardiology Review >Evidence for Benefit of Percutaneous Coronary Intervention for Chronically Occluded Coronary Arteries (CTO) – Clinical and Health Economic Outcomes
【2h】

Evidence for Benefit of Percutaneous Coronary Intervention for Chronically Occluded Coronary Arteries (CTO) – Clinical and Health Economic Outcomes

机译:经皮冠状动脉介入治疗慢性阻塞性冠状动脉(CTO)获益的证据–临床和卫生方面的经济成果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Percutaneous revascularisation of a coronary chronic total occlusion (CTO) remains one of the technical frontiers of interventional cardiology. CTOs are common, and yet intervention is only attempted in 10 % of cases. CTO procedures are perceived to be technically challenging, lengthy, associated with significant risk and have only limited data to support the practise. Recent technical advances have dramatically increased the success rate, shortened procedural time and improved clinical outcomes. The aim of this article is to critically examine the data that supports CTO intervention, including specifically an appraisal of procedural safety, benefit and overall cost effectiveness.
机译:冠状动脉慢性完全阻塞(CTO)的经皮血管再形成仍然是介入心脏病学的技术前沿之一。 CTO很常见,但仅在10%的病例中尝试进行干预。 CTO程序被认为在技术上具有挑战性,冗长,与重大风险相关,并且仅有有限的数据来支持该实践。最近的技术进步大大提高了成功率,缩短了手术时间并改善了临床效果。本文的目的是对支持CTO干预的数据进行严格审查,特别是对程序安全性,收益和总体成本效益的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号